The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented...
Hence then, the article about co diagnostics inc announces intention to submit enhanced version of covid 19 test to fda for 510 k clearance was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance )
Also on site :
- How a shady tax preparer’s practices can lead to costly IRS trouble
- GardePro Launches World's First 3,000ft (1km) Long Range Wireless Trail Camera, Breaking WiFi Distance Limits
- Southern Africa: SADC and Unodc Convene Regional Workshop to Tackle Mineral Crimes